Effects of low-dose losartan treatment on persistent microalbuminuria in normotensive Type 1 diabetic subjects

Journal of Endocrinological Investigation

Volumn 24, Issue 8, 2001, Pages 608-611

  Acbay O ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Losartan; Microalbuminuria; Type 1 diabetes mellitus

Indexed keywords

ALBUMIN; ANGIOTENSIN II ANTAGONIST; CREATININE; ENALAPRIL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MALE; MICROALBUMINURIA; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

EID: 0034779410     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343901     Document Type: Article

References (19)

1. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
2. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria
3. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients
4. Effective postopenement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria
5. The role of angiotensin II and bradykinin in experimental diabetic nephropathy: Functional and structural studies
6. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial
7. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta analysis
8. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
9. Pathogenesis, prevention, and treatment of diabetic nephropathy
10. Prevention of diabetic renal disease with special reference to microalbuminuria
11. Angiotensin receptors and their antagonists
12. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension
13. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes
14. Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats
15. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
16. Angiotensin II receptor antagonists
17. Long-term comparison of losartan and enalapril on kidney function in hypertensive Type 2 diabetics with early nephropathy
18. Effect of long-term losartan administration on renal haemodynamics and function in hypertensive patients
19. Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus